Clinical Trial Update: Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing glucagon's cardiovascular effects with and without beta-blocker–induced cardioinhibition has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Overdose
• Overdose of Beta-adrenergic Blocking Drug

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: University Hospital Bispebjerg and Frederiksberg | Conditions: Drug Overdose, Overdose of Beta-adrenergic Blocking Drug | Phase 4 | Status: COMPLETED